Acclarent closes $28mm second round
Surgical device company Acclarent brought in $28mm with its Series B financing to existing shareholders New Enterprise Associates and Versant Ventures.
- Medical Devices
- Surgical Equipment & Devices
- Venture Financing
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.